Global Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

According to APO Research, The global Cell Therapy market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cell Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Cell Therapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology and Golden Meditech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes


This report presents an overview of global market for Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.


Cell Therapy Segment by Company

Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech

Cell Therapy Segment by Type

Stem Cell
Non-Stem Cell

Cell Therapy Segment by Application

Hospital
Clinic

Cell Therapy Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Therapy industry.
Chapter 3: Detailed analysis of Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Therapyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Cell Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell
1.2.3 Non-Stem Cell
1.3 Market Analysis by Application
1.3.1 Global Cell Therapy Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Market Growth Prospects
1.5 Global Cell Therapy Growth Trends by Region
1.5.1 Global Cell Therapy Market Size by Region: 2020 VS 2024 VS 2031
1.5.2 Cell Therapy Market Size by Region (2020-2025)
1.5.3 Cell Therapy Market Size by Region (2026-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 Global Cell Therapy Market Dynamics
2.1 Cell Therapy Industry Trends
2.2 Cell Therapy Industry Drivers
2.3 Cell Therapy Industry Opportunities and Challenges
2.4 Cell Therapy Industry Restraints
3 Competitive Landscape by Company
3.1 Global Cell Therapy Revenue by Company (2020-2025)
3.2 Global Cell Therapy Players Revenue Ranking, 2023 VS 2024 VS 2025
3.3 Global Cell Therapy Key Company Head office and Area Served
3.4 Global Cell Therapy Company, Product Type & Application
3.5 Global Cell Therapy Company Establishment Date
3.6 Market Competitive Analysis
3.6.1 Global Cell Therapy Market CR5 and HHI
3.6.2 Global Top 5 and 10 Cell Therapy Players Market Share by Revenue in 2024
3.6.3 2024 Cell Therapy Tier 1, Tier 2, and Tier 3
4 Cell Therapy Market by Type
4.1 Global Cell Therapy Market Size by Type (2020 VS 2024 VS 2031)
4.2 Global Cell Therapy Market Size by Type (2020-2031)
4.3 Global Cell Therapy Market Size Share by Type (2020-2031)
5 Cell Therapy Market by Application
5.1 Global Cell Therapy Market Size by Application (2020 VS 2024 VS 2031)
5.2 Global Cell Therapy Market Size by Application (2020-2031)
5.3 Global Cell Therapy Market Size Share by Application (2020-2031)
6 Company Profiles
6.1 Gilead Sciences
6.1.1 Gilead Sciences Comapny Information
6.1.2 Gilead Sciences Business Overview
6.1.3 Gilead Sciences Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.1.4 Gilead Sciences Cell Therapy Product Portfolio
6.1.5 Gilead Sciences Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.2.4 Novartis Cell Therapy Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Osiris
6.3.1 Osiris Comapny Information
6.3.2 Osiris Business Overview
6.3.3 Osiris Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.3.4 Osiris Cell Therapy Product Portfolio
6.3.5 Osiris Recent Developments
6.4 Vericel Corporation
6.4.1 Vericel Corporation Comapny Information
6.4.2 Vericel Corporation Business Overview
6.4.3 Vericel Corporation Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.4.4 Vericel Corporation Cell Therapy Product Portfolio
6.4.5 Vericel Corporation Recent Developments
6.5 Vcanbio
6.5.1 Vcanbio Comapny Information
6.5.2 Vcanbio Business Overview
6.5.3 Vcanbio Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.5.4 Vcanbio Cell Therapy Product Portfolio
6.5.5 Vcanbio Recent Developments
6.6 Fujifilm Cellular Dynamics
6.6.1 Fujifilm Cellular Dynamics Comapny Information
6.6.2 Fujifilm Cellular Dynamics Business Overview
6.6.3 Fujifilm Cellular Dynamics Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.6.4 Fujifilm Cellular Dynamics Cell Therapy Product Portfolio
6.6.5 Fujifilm Cellular Dynamics Recent Developments
6.7 JCR Pharmaceuticals
6.7.1 JCR Pharmaceuticals Comapny Information
6.7.2 JCR Pharmaceuticals Business Overview
6.7.3 JCR Pharmaceuticals Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.7.4 JCR Pharmaceuticals Cell Therapy Product Portfolio
6.7.5 JCR Pharmaceuticals Recent Developments
6.8 Beike Biotechnology
6.8.1 Beike Biotechnology Comapny Information
6.8.2 Beike Biotechnology Business Overview
6.8.3 Beike Biotechnology Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.8.4 Beike Biotechnology Cell Therapy Product Portfolio
6.8.5 Beike Biotechnology Recent Developments
6.9 Golden Meditech
6.9.1 Golden Meditech Comapny Information
6.9.2 Golden Meditech Business Overview
6.9.3 Golden Meditech Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.9.4 Golden Meditech Cell Therapy Product Portfolio
6.9.5 Golden Meditech Recent Developments
6.10 Guanhao Biotech
6.10.1 Guanhao Biotech Comapny Information
6.10.2 Guanhao Biotech Business Overview
6.10.3 Guanhao Biotech Cell Therapy Revenue and Gross Margin (US$ Million) & (2020-2025)
6.10.4 Guanhao Biotech Cell Therapy Product Portfolio
6.10.5 Guanhao Biotech Recent Developments
7 North America
7.1 North America Cell Therapy Market Size (2020-2031)
7.2 North America Cell Therapy Market Size by Type
7.2.1 North America Cell Therapy Market Size by Type (2020-2025)
7.2.2 North America Cell Therapy Market Size by Type (2026-2031)
7.2.3 North America Cell Therapy Market Share by Type (2020-2031)
7.3 North America Cell Therapy Market Size by Application
7.3.1 North America Cell Therapy Market Size by Application (2020-2025)
7.3.2 North America Cell Therapy Market Size by Application (2026-2031)
7.3.3 North America Cell Therapy Market Share by Application (2020-2031)
7.4 North America Cell Therapy Market Size by Country
7.4.1 North America Cell Therapy Market Size by Country (2020 VS 2024 VS 2031)
7.4.2 North America Cell Therapy Market Size by Country (2020-2025)
7.4.3 North America Cell Therapy Market Size by Country (2026-2031)
7.4.4 North America Cell Therapy Market Share by Country (2020-2031)
7.4.5 United States
7.4.6 Canada
7.4.7 Mexico
8 Europe
8.1 Europe Cell Therapy Market Size (2020-2031)
8.2 Europe Cell Therapy Market Size by Type
8.2.1 Europe Cell Therapy Market Size by Type (2020-2025)
8.2.2 Europe Cell Therapy Market Size by Type (2026-2031)
8.2.3 Europe Cell Therapy Market Share by Type (2020-2031)
8.3 Europe Cell Therapy Market Size by Application
8.3.1 Europe Cell Therapy Market Size by Application (2020-2025)
8.3.2 Europe Cell Therapy Market Size by Application (2026-2031)
8.3.3 Europe Cell Therapy Market Share by Application (2020-2031)
8.4 Europe Cell Therapy Market Size by Country
8.4.1 Europe Cell Therapy Market Size by Country (2020 VS 2024 VS 2031)
8.4.2 Europe Cell Therapy Market Size by Country (2020-2025)
8.4.3 Europe Cell Therapy Market Size by Country (2026-2031)
8.4.4 Europe Cell Therapy Market Share by Country (2020-2031)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 China
9.1 China Cell Therapy Market Size (2020-2031)
9.2 China Cell Therapy Market Size by Type
9.2.1 China Cell Therapy Market Size by Type (2020-2025)
9.2.2 China Cell Therapy Market Size by Type (2026-2031)
9.2.3 China Cell Therapy Market Share by Type (2020-2031)
9.3 China Cell Therapy Market Size by Application
9.3.1 China Cell Therapy Market Size by Application (2020-2025)
9.3.2 China Cell Therapy Market Size by Application (2026-2031)
9.3.3 China Cell Therapy Market Share by Application (2020-2031)
10 Asia (Excluding China)
10.1 Asia Cell Therapy Market Size (2020-2031)
10.2 Asia Cell Therapy Market Size by Type
10.2.1 Asia Cell Therapy Market Size by Type (2020-2025)
10.2.2 Asia Cell Therapy Market Size by Type (2026-2031)
10.2.3 Asia Cell Therapy Market Share by Type (2020-2031)
10.3 Asia Cell Therapy Market Size by Application
10.3.1 Asia Cell Therapy Market Size by Application (2020-2025)
10.3.2 Asia Cell Therapy Market Size by Application (2026-2031)
10.3.3 Asia Cell Therapy Market Share by Application (2020-2031)
10.4 Asia Cell Therapy Market Size by Country
10.4.1 Asia Cell Therapy Market Size by Country (2020 VS 2024 VS 2031)
10.4.2 Asia Cell Therapy Market Size by Country (2020-2025)
10.4.3 Asia Cell Therapy Market Size by Country (2026-2031)
10.4.4 Asia Cell Therapy Market Share by Country (2020-2031)
10.4.5 Japan
10.4.6 South Korea
10.4.7 Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 South America, Middle East & Africa
11.1 South America, Middle East & Africa Cell Therapy Market Size (2020-2031)
11.2 South America, Middle East & Africa Cell Therapy Market Size by Type
11.2.1 South America, Middle East & Africa Cell Therapy Market Size by Type (2020-2025)
11.2.2 South America, Middle East & Africa Cell Therapy Market Size by Type (2026-2031)
11.2.3 South America, Middle East & Africa Cell Therapy Market Share by Type (2020-2031)
11.3 South America, Middle East & Africa Cell Therapy Market Size by Application
11.3.1 South America, Middle East & Africa Cell Therapy Market Size by Application (2020-2025)
11.3.2 South America, Middle East & Africa Cell Therapy Market Size by Application (2026-2031)
11.3.3 South America, Middle East & Africa Cell Therapy Market Share by Application (2020-2031)
11.4 South America, Middle East & Africa Cell Therapy Market Size by Country
11.4.1 South America, Middle East & Africa Cell Therapy Market Size by Country (2020 VS 2024 VS 2031)
11.4.2 South America, Middle East & Africa Cell Therapy Market Size by Country (2020-2025)
11.4.3 South America, Middle East & Africa Cell Therapy Market Size by Country (2026-2031)
11.4.4 South America, Middle East & Africa Cell Therapy Market Share by Country (2020-2031)
11.4.5 Brazil
11.4.6 South Africa
11.4.7 Saudi Arabia
11.4.8 Turkey
11.4.9 Argentina
11.4.9 UAE
11.4.9 Egypt
11.4.9 Chile
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings